Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Veralto
VLTO
$23.9B
| $91.5M | 0.02% |
+1,111,889
| New | +$83M |
|
602
Saia
SAIA
$9.52B
| $91.5M | 0.02% |
208,711
+2,801
| +1% | +$1.13M |
|
603
e.l.f. Beauty
ELF
$5.61B
| $91.2M | 0.02% |
631,550
+24,191
| +4% | +$2.79M |
|
604
Vistra
VST
$48.6B
| $91M | 0.02% |
2,363,177
-84,008
| -3% | -$2.92M |
|
605
Onto Innovation
ONTO
$19.5B
| $90.9M | 0.02% |
594,755
-6,388
| -1% | -$859K |
|
606
Qualys
QLYS
$6.51B
| $90.9M | 0.02% |
463,270
-6,461
| -1% | -$1.13M |
|
607
C.H. Robinson
CHRW
$17B
| $90.9M | 0.02% |
1,052,240
+28,005
| +3% | +$2.35M |
|
608
Neurocrine Biosciences
NBIX
$16.5B
| $90.5M | 0.02% |
686,835
+63,568
| +10% | +$7.32M |
|
609
Omega Healthcare
OHI
$13.8B
| $90.4M | 0.02% |
2,948,554
+124,483
| +4% | +$3.99M |
|
610
Match Group
MTCH
$8.45B
| $90M | 0.02% |
2,466,837
+51,179
| +2% | +$1.73M |
|
611
Domino's
DPZ
$11.8B
| $89.9M | 0.02% |
218,019
+6,864
| +3% | +$2.57M |
|
|
DAY
612
DELISTED
Dayforce
DAY
| $89.7M | 0.02% |
1,336,539
+38,691
| +3% | +$2.64M |
|
613
RPM International
RPM
$14.9B
| $89.5M | 0.02% |
801,640
+19,866
| +3% | +$2.01M |
|
614
Atkore
ATKR
$3.17B
| $89.3M | 0.02% |
557,985
+17,012
| +3% | +$2.35M |
|
615
Leggett & Platt
LEG
$1.3B
| $89.3M | 0.02% |
3,410,398
-2,821,239
| -45% | -$69.2M |
|
616
F5
FFIV
$23.4B
| $89.1M | 0.02% |
497,631
+9,830
| +2% | +$1.6M |
|
617
Universal Health Services
UHS
$9.94B
| $88.8M | 0.02% |
582,809
+5,557
| +1% | +$748K |
|
618
Brown & Brown
BRO
$23.9B
| $88.7M | 0.02% |
1,247,971
+26,075
| +2% | +$1.86M |
|
619
Insulet
PODD
$10B
| $88.4M | 0.02% |
407,592
+22,247
| +6% | +$3.82M |
|
620
Globe Life
GL
$14.1B
| $88.4M | 0.02% |
726,086
+6,830
| +0.9% | +$803K |
|
621
New York Times
NYT
$10.3B
| $88.2M | 0.02% |
1,800,927
+31,213
| +2% | +$1.38M |
|
622
Dropbox
DBX
$7.41B
| $88.2M | 0.02% |
2,990,186
+98,568
| +3% | +$2.74M |
|
623
Owens Corning
OC
$12.6B
| $88.1M | 0.02% |
594,132
+3,111
| +0.5% | +$412K |
|
624
Lennox International
LII
$14.9B
| $87.8M | 0.02% |
196,172
+4,211
| +2% | +$1.68M |
|
625
Graco
GGG
$13.5B
| $87.7M | 0.02% |
1,011,221
+22,590
| +2% | +$1.78M |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.